NYSE$MG
Mistras Group Inc · Q1 2025 earnings
Q1 2025 earnings · · After market close · Investor relations
Briefing
Mistras Group reported Q1 2025 revenue of $161.6M, a net loss of $3.2M, diluted EPS of $-0.10.
For Q1 2025, Mistras Group reported Revenue was $161.6M, net loss was $3.2M, diluted EPS was $-0.10. Management discusses segment trends, liquidity, and outlook in the quarterly filing.
- Revenue $161.6M for Q1 2025.
- Net loss $3.2M.
- Diluted EPS $-0.10.
Headline financials
Revenue & EPS history
Mistras · Revenue · Quarterly
$162M
Revenue by segment
Mistras · $183M total across 3 segments · Q3 2023
- North America$149M—81.5%
- International$31M+20.6%17.0%
- Products and Systems$2.83M-8.1%1.5%
Forward guidance
Biotech outlook emphasizes pipeline milestones, collaboration funding, and cash runway.
Tailwinds
- Partnership revenue and milestone potential.
- Clinical progress on lead programs.
Headwinds
- Operating losses and dilution risk.
- Regulatory and trial execution uncertainty.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2025
+0.5%
Avg return
Earnings day
-1.5%
Avg return
5 days after
+1.1%
Avg return
30 days after
56%
35 / 62 earnings
Positive
+41.9%
Q1 2015
Best reaction
-25.0%
Q3 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +1.0% | -9.1% | -5.8% | |
| Q4 2025 | -5.8% | -8.2% | -2.4% | |
| Q3 2025 | +0.1% | -1.0% | +24.0% | |
| Q1 2025 | -0.4% | -6.9% | -2.6% | |
| Q4 2024 | +12.2% | +7.9% | +1.4% | |
| Q3 2024 | -25.0% | -25.5% | -17.4% | |
| Q2 2024 | +1.0% | -1.3% | +19.2% | |
| Q1 2024 | +5.6% | +2.3% | -2.3% | |
| Q4 2023 | +8.1% | +7.6% | +15.6% | |
| Q3 2023 | +10.2% | +10.8% | +24.3% | |
| Q2 2023 | -21.4% | -31.1% | -30.9% | |
| Q1 2023 | -15.8% | -14.2% | -14.2% | |
| Q4 2022 | +3.0% | +5.6% | +38.2% | |
| Q3 2022 | -13.4% | -10.9% | -24.3% | |
| Q2 2022 | +2.7% | +0.0% | -14.8% | |
| Q1 2022 | +4.0% | -3.3% | +2.8% | |
| Q4 2021 | -0.2% | +2.5% | -3.5% | |
| Q3 2021 | -10.6% | -11.6% | -25.3% | |
| Q2 2021 | +0.8% | -1.6% | +0.6% | |
| Q1 2021 | -4.0% | -15.0% | -10.1% | |
| Q4 2020 | +9.9% | +6.3% | +7.0% | |
| Q3 2020 | +4.9% | +22.3% | +52.1% | |
| Q2 2020 | +18.2% | +21.5% | +24.9% | |
| Q1 2020 | +2.5% | +15.6% | +33.4% | |
| Q4 2019 | +6.0% | +11.5% | -4.5% | |
| Q3 2019 | -11.2% | -8.5% | -14.7% | |
| Q2 2019 | +12.0% | +11.3% | -1.8% | |
| Q1 2019 | -5.2% | -3.6% | +0.6% | |
| Q4 2018 | -9.0% | -8.7% | -12.1% | |
| Q3 2018 | -12.3% | -11.3% | -17.6% | |
| Q2 2018 | +13.5% | +9.3% | +10.7% | |
| Q1 2018 | +1.1% | -6.2% | +0.7% | |
| Q4 2017 | -2.7% | -2.8% | -1.9% | |
| Q3 2017 | +6.6% | +5.8% | +6.4% | |
| Q2 2017 | -5.3% | -11.0% | -1.4% | |
| Q1 2017 | +1.1% | -2.9% | -7.2% | |
| Q4 2016 | -11.3% | -1.9% | -6.6% | |
| Q3 2016 | -6.4% | — | — | |
| Q2 2016 | +15.6% | — | — | |
| Q1 2015 | +41.9% | — | — | |
| Q4 2015 | -14.7% | — | — | |
| Q3 2015 | -2.0% | — | — | |
| Q2 2015 | +17.9% | — | — | |
| Q3 2014 | -3.1% | — | — | |
| Q2 2014 | +3.0% | — | — | |
| Q1 2014 | +1.8% | — | — | |
| Q4 2013 | +10.5% | — | — | |
| Q3 2013 | +6.7% | — | — | |
| Q2 2013 | -4.7% | — | — | |
| Q1 2013 | -12.5% | — | — | |
| Q4 2012 | -10.7% | — | — | |
| Q3 2012 | -1.8% | — | — | |
| Q2 2012 | +2.3% | — | — | |
| Q1 2012 | +0.0% | — | — | |
| Q4 2011 | -6.7% | — | — | |
| Q3 2011 | +5.2% | — | — | |
| Q2 2011 | +10.3% | — | — | |
| Q1 2011 | +4.7% | — | — | |
| Q4 2010 | +1.7% | — | — | |
| Q3 2010 | -0.5% | — | — | |
| Q2 2010 | +2.5% | — | — | |
| Q1 2009 | +0.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro